These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8157719)

  • 21. Comparative study of the changes in insulin-like growth factor-I, procollagen-III N-terminal extension peptide, bone Gla-protein, and bone mineral content in children with Turner's syndrome treated with recombinant growth hormone.
    Bergmann P; Valsamis J; Van Perborgh J; De Schepper J; Van Vliet G
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1461-7. PubMed ID: 2229302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome.
    Reiter EO; Blethen SL; Baptista J; Price L
    J Clin Endocrinol Metab; 2001 May; 86(5):1936-41. PubMed ID: 11344188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.
    Ross JL; Cassorla F; Carpenter G; Long LM; Royster MS; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained effect of human growth hormone therapy on children with intrauterine growth retardation.
    Lanes R; Plotnick LP; Lee PA
    Pediatrics; 1979 May; 63(5):731-5. PubMed ID: 571599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
    Schweizer R; Martin DD; Schönau E; Ranke MB
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New findings and the potential use of the growth hormone].
    Sotos JF
    An Esp Pediatr; 1992 Jun; 36 Suppl 48():166-9. PubMed ID: 1636958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy.
    Roemmich JN; Huerta MG; Sundaresan SM; Rogol AD
    Metabolism; 2001 May; 50(5):537-47. PubMed ID: 11319714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GH assessment and three years' hGH therapy in girls with Turner syndrome.
    Pasquino AM; Bernardini S; Cianfarani S; Mancuso G; Marchione SA; Passèri F; Pucarelli I; Spadoni GL
    Horm Res; 1992; 38(3-4):120-4. PubMed ID: 1306842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone and body composition in athletes.
    Frisch H
    J Endocrinol Invest; 1999; 22(5 Suppl):106-9. PubMed ID: 10442579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effects of treatment with growth hormone alone or in combination with oxandrolone in a group of Turner's syndrome children. A preliminary study].
    Cherubini V; Cardinale G; Panfoli C; Pecora R; Lorenzetti L; Bartolotta E
    Minerva Pediatr; 1991 Jun; 43(6):465-9. PubMed ID: 1886533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
    Bengtsson BA; Edén S; Lönn L; Kvist H; Stokland A; Lindstedt G; Bosaeus I; Tölli J; Sjöström L; Isaksson OG
    J Clin Endocrinol Metab; 1993 Feb; 76(2):309-17. PubMed ID: 8432773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
    Gravholt CH; Hjerrild BE; Naeraa RW; Engbaek F; Mosekilde L; Christiansen JS
    Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related perception of stature, acceptance of therapy, and psychosocial functioning in human growth hormone-treated girls with Turner's syndrome.
    Lagrou K; Xhrouet-Heinrichs D; Heinrichs C; Craen M; Chanoine JP; Malvaux P; Bourguignon JP
    J Clin Endocrinol Metab; 1998 May; 83(5):1494-501. PubMed ID: 9589645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body fat in GH-deficient children and the effect of treatment.
    Wabitsch M; Heinze E
    Horm Res; 1993; 40(1-3):5-9. PubMed ID: 8300050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stature after 18 months of treatment with synthetic growth hormone in 12 patients with Turner's syndrome].
    Leheup B; Pierson M
    J Genet Hum; 1989 Jan; 37(1):55-60. PubMed ID: 2715783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative rapidity of response of height, limb muscle and limb fat to treatment with human growth hormone in patients with and without growth hormone deficiency.
    Tanner JM; Hughes PC; Whitehouse RH
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):681-96. PubMed ID: 576755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of growth hormone secretion in patients with intrauterine growth retardation.
    Rochiccioli P; Tauber M; Moisan V; Pienkowski C
    Acta Paediatr Scand Suppl; 1989; 349():42-6; discussion 53-4. PubMed ID: 2501968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone therapy in short children without classical growth hormone deficiency.
    Bierich JR
    J Endocrinol Invest; 1989; 12(8 Suppl 3):25-33. PubMed ID: 2681346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.